Commonwealth Equity Services, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Commonwealth Equity Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$3.99 - $17.73 $56,889 - $252,794	-14,258 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$11.19 - $16.92 $159,547 - $241,245	14,258 New	14,258 $241,000
Q1 2020 May 11, 2020	SELL	$4.01 - $8.88 $47,582 - $105,370	-11,866 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$3.62 - $4.29 $362 - $429	100 Added 0.85%	11,866 $50,000
Q4 2017 Feb 12, 2018	BUY	$2.96 - $4.42 $34,827 - $52,005	11,766	11,766 $46,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.